glp 1 law suit Trulicity Lawsuit [2026] Ozempic's double-sided coin: Amid skyrocketing
Description
Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Enhanced with Vitamin C and Hyaluronic Acid
![glp 1 law suit Trulicity Lawsuit [2026] Ozempic's double-sided coin: Amid skyrocketing](https://images.passle.net/fit-in/860x860/Passle/6570e4e6056d459875ee21dd/SearchServiceImages/2026-03-24-20-06-12-764-69c2eeb48045f48f34c8ad30.jpg)
Surgeon's guide to the evidence, symptoms and when to seek assessment in Hampshire.
![glp 1 law suit Trulicity Lawsuit [2026] Ozempic's double-sided coin: Amid skyrocketing](https://www.reuters.com/resizer/v2/WMAWOBMJPJJDHCVIO2PT3NCP3E.jpg?auth=f050c9e17632285b125092f1ceb887ed8df0206e2c2018188b16a3347df0041e&width=1920&quality=80)
Semaglutide, known by names like Ozempic or Wegovy, has transformed obesity and diabetes care
![glp 1 law suit Trulicity Lawsuit [2026] Ozempic's double-sided coin: Amid skyrocketing](https://www.salvilaw.com/wp-content/uploads/2026/04/GLP-1.jpg)
The weight-loss effects of GLP-1 drugs have little to do with the gut.
This is why variety in your prep is so important